HomeIndustriesHomebuilding & Real EstateModerna (MRNA) CFO On Covid Vaccine Demand & Earnings
00:00
00:00
09:08
Moderna (MRNA) CFO On Covid Vaccine Demand & Earnings

Moderna (MRNA) CFO On Covid Vaccine Demand & Earnings

Moderna (MRNA) posts a wider loss and cuts guidance as Covid vaccine sales drop. Its adjusted EPS came in at -$9.53 versus an estimated -$2.01 and revenue came in at $1.83B versus an estimated $1.33B. Moderna CFO Jamey Mock joins Oliver Renick to give an overview of the company. He talks about how MRNA sees at least $6B of Covid-19 vaccine sales in 2023. MRNA expects 50M doses in the U.S. this fall, which was previously estimated at 50M-100M doses. Mock then goes over what’s in the pipeline for MRNA. Tune in to find out more about the stock market today.

Market On Close

02 Nov 2023

SHARE

ON AIR
1:00 am
Gamma On
replay
5:00 am
Gamma On
REPLAY
5:30 am
Gamma On
REPLAY
6:00 am
Gamma On
REPLAY
6:30 am
Gamma On
REPLAY
7:30 am
Gamma On
REPLAY
8:00 am
Gamma On
REPLAY
8:30 am
Gamma On
REPLAY
9:00 am
Gamma On
REPLAY
10:00 am
Gamma On
REPLAY
11:00 am
Gamma On
REPLAY
12:00 pm
Morning Movers
1:00 pm
Morning Trade Live
3:00 pm
Trading 360
4:00 pm
Fast Market
5:00 pm
Next Gen Investing
6:00 pm
The Watch List
7:00 pm
Market On Close
8:30 pm
Market Overtime
REPLAY
9:00 pm
Trading 360
REPLAY
10:00 pm
Fast Market
REPLAY
11:00 pm
Next Gen Investing
REPLAY
12:00 am
Market Overtime
REPLAY
12:30 am
Market Overtime
REPLAY
ON AIR
1:00 am
Gamma On
REPLAY
2:00 am
Market Overtime
REPLAY
2:30 am
Market Overtime
REPLAY
education
3:00 am
Inside the Mind of a Trader
REPLAY
education
3:30 am
Inside the Mind of a Trader
REPLAY
education
4:00 am
Inside the Mind of a Trader
REPLAY
education
4:30 am
Your First Trade
REPLAY

Schwab Network's Newsletters

Daily insights for every investor